[HTML][HTML] Nuclear imaging in cardiac amyloidosis

A Glaudemans, R Slart, CJ Zeebregts… - European journal of …, 2009 - Springer
Amyloidosis is a disease characterized by depositions of amyloid in organs and tissues. It
can be localized (in just one organ) or systemic. Cardiac amyloidosis is a debilitating …

Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin

C Aprile, G Marinone, R Saponaro, C Bonino… - European journal of …, 1995 - Springer
Antiproteases are known to be present in amyloid deposits. We evaluated the possibility of
using an anti-serine protease (aprotinin) labelled with technetium-99m (TcA), usually …

[HTML][HTML] Functional imaging techniques for evaluation of sarcomas

RJ Hicks - Cancer imaging, 2005 - ncbi.nlm.nih.gov
Sarcomas are often characterised by significant histopathologic heterogeneity, both
between and within tumours. This heterogeneity reflects physiologic, biochemical and …

Diagnostic value of Tc-99m (V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy

H Kobayashi, Y Kotoura, M Hosono… - Clinical nuclear …, 1995 - journals.lww.com
Abstract Technetium-99m (V) DMSA scintigraphy was performed In 17 patients with 37
chondrogenic tumors (13 osteochondromas, 14 enchondromas, and 10 chondrosarcomas) …

Pentavalent 99Tcm-DMSA imaging in patients with bone metastases

ASK Lam, AG Kettle, MJ O'doherty… - Nuclear medicine …, 1997 - journals.lww.com
Pentavalent 99 Tc m-dimercaptosuccinic acid (99 Tc m-(V) DMSA) has an established role
in imaging medullary thyroid carcinoma. There have been case reports of uptake in bone …

In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid

ASK Lam, MRB Puncher, PJ Blower - European journal of nuclear …, 1996 - Springer
The purpose of this investigation was to characterise the in vivo chemistry and binding
mechanisms of technetium-99m dimercaptosuccinic acid [99m Tc (V) DMSA]. Biodistribution …

Both a visual and a semiquantitative analysis for differentiating benign from malignant chondrogenic bone tumors using Tc-99m (V) DMSA scintigraphy: a prospective …

T Shinya, S Sato, T Kunisada, R Inai… - Nuclear medicine …, 2015 - journals.lww.com
Objective The aims of this prospective study were to assess the relationship between tumor
aggressiveness and Tc-99m (V) dimercaptosuccinic acid (DMSA) uptake in chondrogenic …

Differentiation of pituitary adenomas from other sellar and parasellar tumors by 99mTc (V)-DMSA scintigraphy

K Yamamura, S Suzuki, I Yamamoto - Neurologia medico-chirurgica, 2003 - jstage.jst.go.jp
Pentavalent technetium-99m dimercaptosuccinic acid [99mTc (V)-DMSA] scintigraphy was
evaluated for the differentiation of pituitary adenomas, especially non-functioning …

Scan findings of various myocardial SPECT agents in a case of amyloid polyneuropathy with suspected myocardial involvement

AS Arbab, K Koizumi, K Toyama, T Arai… - Annals of nuclear …, 1997 - Springer
A 31-year-old male having familial amyloid polyneuropathy underwent a Tc-99m (V)-DMSA
study to evaluate the myocardial involvement. The patient also underwent Tl-201, I-123 …

Solitary muscular involvement by tuberculosis: CT, MRI, and scintigraphic features

H Kobayashi, Y Kotoura, M Hosono… - … medical imaging and …, 1995 - Elsevier
The authors reported computed tomography (CT), magnetic resonance imaging (MRI) and
scintigraphic findings of a patient with solitary muscular tuberculosis in the forearm. All these …